Indeed, AXL was expressed in tumor vessels (87.5%, n = 266), in HCC tumor cells (4.28%, n = 13), and in both HCC tumor cells and TECs (8.22%, n = 25) of total samples. The gene discussed is AXL; the disease is hepatocellular carcinoma.